CVS Health declares quarterly dividend of $0.665 per share

WOONSOCKET, R.I. - CVS Health (NYSE:CVS) announced Monday that its board of directors has approved a quarterly dividend of $0.665 per share on the company’s common stock.

The dividend will be payable on August 1, 2025, to shareholders of record as of July 22, 2025, according to a press release statement from the healthcare company.

CVS Health operates more than 9,000 retail pharmacy locations and over 1,000 walk-in and primary care medical clinics across the United States. With annual revenue of $376.74 billion and a market capitalization of $84.63 billion, the company maintains a strong market presence. The company also manages a pharmacy benefits manager serving approximately 88 million plan members and provides healthcare services to more than 37 million people through various insurance products. According to InvestingPro analysis, CVS currently appears undervalued based on its Fair Value estimate.

The company’s senior pharmacy care business serves more than 800,000 patients annually, and CVS offers Medicare Advantage offerings and a standalone Medicare Part D prescription drug plan.

The quarterly dividend announcement comes as part of the company’s regular financial operations and shareholder returns program.

In other recent news, CVS Health’s pharmacy benefit manager unit was ordered by a federal judge to pay $95 million to the U.S. government for overcharging Medicare for prescription drugs. This decision comes after a whistleblower lawsuit claimed that CVS Caremark inflated claims submitted to Medicare, with further discussions to potentially increase the penalty to $285 million. Meanwhile, CVS Health has opened a new Workforce Innovation and Talent Center in Chicago, aimed at providing job training for community members, including positions as pharmacy technicians and retail associates. This initiative is part of CVS Health’s broader community involvement, which includes significant investments in affordable housing and health services.

Additionally, CVS Health’s Aetna division participated in a meeting with the U.S. health secretary and other major insurers to simplify prior authorization processes for medications and medical services. This move aims to reduce administrative burdens in the healthcare system. In legislative developments, CVS Health benefited from the removal of Medicare Pharmacy Benefit Manager limits from a tax bill, which eased regulatory pressures on its operations. This change also positively impacted other healthcare companies with significant PBM operations. In related discussions, Senate Republicans are considering cuts to Medicare spending to fund a tax bill, focusing on reducing payments to private Medicare Advantage insurers.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.